2022 Annual Aspen Allergy Conference

Aspen, CO US

The Aspen Allergy Conference is an interactive four consecutive half-day and thematic meeting with educational sessions including: Asthma, Allergy, Immunodeficiency and COVID. Each State of the Art speaker is selected by their expertise in the topic they are asked to speak. Each lecture is 45 minutes in length with 15 minutes of questions, answers and scientific discussion. The discussion time is protected as a premium advantage for the attendee to maximize the learning experience. There is also ample time for the speaker and attendees to discuss the basic science, translational and clinical topics at length during the course of the meeting. One oral abstract per day is included in the program with a five minute question and answer period. In addition, posters are included, typically 15-20, that are submitted by physicians including fellows-in-training on topics pertinent to Allergy, Asthma and Immunology. Formal and informal times are included for the presenters and attendees to discuss the scientific basis of the posters at this meeting. Our conference is unique holding two “Meet the Professor” question and answer session along with a Nature Botany Walk.

Registration Fees
Attendee TypeFee
Colorado Allergy & Asthma Society (CAAS) Member$0.00
Speaking/Presenting Faculty$0.00
Abstract Presenters$200.00
Non CAAS Physician/PA/Nurse$500.00
Pharmaceutical Representatives$1000.00

Online registration will remain open through 12:00 noon on Monday, July 18.

Credit claiming will be available through June 30, 2023. Credit requests on or after July 1, 2023 will be subject to an administrative fee.


Target Audience

  • Allergist/immunologists
  • Fellows-in-training
  • Nurse Practitioners
  • Nurses

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Understand new treatment options for all asthma syndromes
  • Understand the pathogenesis of a subgroup of asthma patients
  • Understand biologic therapy of asthma
  • Understand the role of biologic in food allergy treatment
  • Understand mechanisms of food allergy
  • Use new treatment approach to Adult EOE Session
  • Appreciate the impact of digital health on A/I
  • Understand the impact of genetics on clinical practice of A/I
  • Understand risk factors for allergy physician burnout
  • Understand new molecular techniques in the study of A/I and immunodeficiency
  • Explain the association of inflammation with immunodeficiency
  • Evaluate and understand the components of immunodeficiency and complications
  • Understand the utility of COVID mRNA Vaccines
  • Understand allergy to COVID vaccines
  • Understand T Cell immunity to COVID
Available credit: 
  • 15.50 Attendance
    Attendance credit.
  • 15.50 CME
    CME credit.
Course opens: 
Course expires: 
Aspen Allergy Conference

Sunday, July 24, 2022


5:30 – 6:30 pm              Product Theater                                                           

6:30 – 7:30 pm              Henry Claman, MD Lecture

                                             Paul A. Offit

                                             Director of the Vaccine Education Center, Professor of Pediatrics, Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA

                                             Moderator:  Lanny Rosenwasser, MD


Monday, July 25, 2022


Noon – 1:00 pm              Product Theater   (Non CME)                 Lunch Provided                                                                                                         
                                             SESSION I: Asthma Session


1:00 - 1:05 pm               Welcome                                       

1:05 - 1:15 pm                           , MD

                                      Overview of Session/Reveal Disclosures

1:15 – 2:15 pm              Geoff Chupp, MD
                                       Professor of Medicine, Yale School of Medicine, Director, Yale Center for Asthma and Airway Disease, Director, Pulmonary Function Laboratory, Yale New Haven Hospital, New Haven, CT

                                      Overview of Changing Patterns of Treatment for Asthma

2:15 – 2:45 pm              Oral Abstract                                                                                       

2:45 – 3:00 pm              Coffee Break & Poster Session


3:00 – 4:00 pm              Elliot Israel, MD

                                      Professor of Medicine, Harvard Medical School, Gloria M. and Anthony C. Simboli Distinguished Chair in Asthma Research, Director of Clinical Research, Pulmonary and Critical Care Division                                       Allergy and Immunology, Brigham & Women’s Hospital, Boston, Massachusettes

                                      CRTH2 and PGD2 in Asthma

4:00 – 5:00 pm              Sally Wenzel, MD 

                                      Professor of Medicine, Chair, Department of Occupational & Environmental Health, Acting Director, Asthma Environmental Lung Health Institute, Rachel Carson Chair in Environmental Health                            University of Pittsburgh, PA

                                      Biologics and Biologic Phenotyping:  Improving the Understanding and Treatment of Severe Asthma



5:00 - 5:10 pm                       , MD

                                      Closing Comments/Adjournment

5:00 - 7:00 pm              Interactive Poster Session

                                      Lanny Rosenwasser, MD


Tuesday, July 26, 2022

7:00 - 8:00 am             Meet the Professor 
                                          , MD,


                                     SESSION II: Food Allergy



8:00 - 8:15 am               , Moderator

                                     Overview of Session/Reveal Disclosures


8:15 - 9:15 am              Evan S. Dellon, MD, MPH

                                      Professor of Medicine and Epidemiology, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC

                                      EoE in Adults

 9:15 - 9:45 am              Oral Abstract


9:45 – 10:00 am             Coffee Break & Poster Session


10:00 – 11:00 am           Wayne Shreffler, MD

                                    Chief, Pediatric Allergy & Immunology, Director, Food Allergy Center, Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA

                                        Mechanisms of Oral Immunology

11:00 – 12:00 pm           David Fleischer, MD, FAAAAI, FACAAI

                                    Section Head, Allergy & immunology, Director, Allergy & Immunology Center, Professor of Pediatrics, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO

                                       Update on the Use of Biologics in the Treatment of Food Allergy


12:00 – 12:05 pm              , Moderator

                                       Closing Comments/Adjournment

12:15 – 1:15 pm             Product Theater              Lunch Provided

1:30 – 3:30 pm                Nature Botany Walk

                                      Aspen Center for Environmental Studies

                                      William Silvers, MD, Moderator



Wednesday, July 27, 2022

12:00 - 1:00 pm              SESSION III:            SARS CoV2

                                       CHAIR:                      , MD


1:00 – 1:15 pm               , MD


                                     Overview of Session/Reveal Disclosures


1:15 – 2:15 pm             Michael O’Connell, PhD

                                     Staff Clinician, Translational Allergic Immunopathology Unit, National Institute of Health, Allergy and Infectious Diseases, Bethesda, MD

                                     mRNA Vaccine Development


2:15 – 2:45 pm             Oral Abstract               



2:45 – 3:45 pm              Aleena Banerji, MD

                                      Associate Professor Allergy/Medicine MGH, Harvard Medical School, Director, Drug Allergy Program, Clinical Director, Allergy and Clinical Immunology, Boston, MA

                                      Allergy to COVID Vaccines


3:45 – 4:15 pm               Ice Cream Social Break


4:15 – 5:15 pm              Carrie Lucas, PhD

                                       Assistant Prof of Medicine and Immunology, Yale University School of Medicine, New Haven, CT

                                       Immune Responses to SARS CoV2


5:15 – 5:20                        , MD, Moderator

                                        Closing Comments/ Adjournment



Thursday, July 28, 2022


7:00 - 8:00 am              Meet the Professor

                                             , MD

                                             , MD, Moderator

                                      SESSION IV:            Immunodeficiency

                                      CHAIRS:                   Charles Kirkpatrick, MD


8:00 - 8:15 am               , MD

                                       , Moderator

                                    Overview of Session/Reveal Disclosures


8:15 - 9:15 am              Joshua David Milner, MD, SB

                                   Chief, Genetics and Pathogenesis of Allergic Disease Section in the NIAID,       National Institutes of Health, Bethesda, MD

                                     New Molecular Techniques for A/I


9:15 – 10:15 am            Lisa Forbes Satter, MD 

                                       Assistant Professor, Department of Pediatrics, Baylor College of Medicine, Immunology Allergy and Retrovirology, William T. Shearer Center for Human Immunobiology, Clinical Director,
                                      Texas Children’s Hospital Mark Wallace Tower Infusion Center, Medical Director, Houston, TX

                                      Inflammation in Immune Deficiency


10:15 – 10:30 am         Coffee Break


10:30 – 11:00 am         Oral Abstract


11:00 – 12:00 pm         Zuhair Ballas, MD

                                     Professor of Internal Medicine – Immunology, Department of Internal Medicine, University of Iowa Health Care, Iowa City, Iowa

                                     Secondary Immune Deficiency Management


12:00 – 12:30 pm        Lanny Rosenwasser, MD

                                    Conference Summary & Closing Comments

Hotel Jerome
330 East Main Street
Aspen, CO 81611
United States
Planning Committee

Fred (Dan) Atkins, MD FAAAAI
Children's Hospital of Colorado, Aurora, CO
Relevant relationships: None

Donna Bratton, MD
National Jewish Health, Cherry Hills Village, CO
Relevant relationships: None

Stephen Dreskin, MD PhD FAAAAI
University of Colorado Denver, Denver, DO
Relevant relationships: Blueprint Medicine: Consultant

Flavia Hoyte, MD
National Jewish Health, Denver, CO
Relevant relationships: Astra Zeneca: advisory board; GSK, Astra Zeneca: speaker; Amgen, Johnson and Johnson, Merck: stock owner

John M. James, MD FAAAAI
Food Allergy Consulting and Education Services, LLC, Fort Collins, CO
Relevant relationships: None

Charles Kirkpatrick, MD FAAAAI
University of Colorado Health Science Center, Denver, CO
Relevant relationships: None

Harold S. Nelson, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: ALK: consultant

Lanny Rosenwasser, MD FAAAAI
University of Colorado Anschutz School of Medicine, Denver, CO
Relevant relationships: None

Alan Schocket, MD MSHA
University of Colorado, Denver, CO
Relevant relationships: None



Zuhair Ballas, MD FAAAAI
University of Iowa Health Care, Iowa City, IA
Relevant relationships:Octapharma: clinical trial

Aleena Banerji, MD FAAAAI
Massachusetts General Hospital, Boston, MA
Relevant relationships: None

Geoffrey Chupp, MD
Yale University, New Haven, CT
Relevant relationships: Amgen, AstraZeneca, Circassia, Genentech, Sanofi-Genzyme, Regeneron: speaker; AstraZeneca, Boehringer Ingelheim, Genentech, GSK: research grant; AstraZeneca, Boehringer Ingelheim, Genentech, Teva: consultant; Amgen, Sanofi-genzyme, Regeneron: advisory board

Evan S. Dellon, MD
University of North Carolina School of Medicine, Chapel Hill, NC
Relevant relationships: Abbott, Abbvie, Adare/ Ellodi, Aimmune, Akesobio, Allakos, Amgen, Arena, AstraZeneca, Avir, Biorasi, Calypso, Celgene/Receptos/BMS, Celldex, Eli Lilly, EsoCap, GSK, Gossamer Bio, Invea, Landos, LucidDx, Morphic, Nutricia, Parexel/Calyx, Phathom, Regeneron, Revolo, Robarts/Alimentiv, Salix, Sanofi, Shire/Takeda, Target RWE: consultant

David Fleischer, MD FAAAAI
Children's Hospital Colorado, Denver, CO
Relevant relationships: Genentech, Novartis: advisory board; Aquestive, DBV Technologies, DOTS Technology Corp, Nasus: consultant

Lisa Forbes Satter, MD FAAAAI
Texas Children's Hospital, Baylor College of Medicine, Houston, TX
Relevant relationships: TBD

Elliot Israel, MD FAAAAI
Brigham and Women's Hospital, Boston, MA
Relevant relationships: AB Science, Amgen, AstraZeneca, Avillion, Cowen, Danaher Lagnese, GlaxoSmithKline, Merck, Novartis, PPS Health, Pneuma Respiratory, Regeneron, Sanofi, SettlePou, TEVA, Vorso Corp, : consultant; UpToDate: royalties

Carrie Lucas, PhD
Yale University, New Haven, CT
Relevant relationships: None

Joshua David Milner, MD FAAAAI
Presbysterian Hospital, New York, NY
Relevant relationships: None

Michael O'Connell, MD FAAAAI
Pfizer, Ponte Vedra, FL
Relevant relationships: Pfizer: stocks

Lanny Rosenwasser, MD FAAAAI
University of Colorado Anschutz School of Medicine, Denver, CO
Relevant relationships: None

Wayne Shreffler, MD PhD FAAAAI
Massachusetts General Hospital / Harvard Medical School, Boston, MA
Relevant relationships: Angany Therapeutics, DBV Technologies, Moderna, NIAID, Novartis, Vedanta Biosciences: research grant

Sally Wenzel, MD FAAAAI
University of Pittsburgh Medical Center NW, Pittsburgh, PA
Relevant relationships: AstraZemeca, GSK, Knopp, Novartis, Sanofi: consultant; Aer THerapeutics: advisory board


Content Reviewers

Jeffrey Chambliss, MD FAAAAI
University of Texas Southwestern
Relevant relationships: None

Brian Kelly, MD
St. Paul Allergy and Asthma, St. Paul, MN
Relevant relationships: None


AAAAI Disclosure Policy

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment. Name of employer and job title.
  • Financial interests. All organizations, other than the employer, from which the faculty member receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests. All organizations which support research projects for which the faculty member serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts. All organizations from which the faculty member have received a gift of any amount in the last year.
  • Other interests. All interests of the faculty member that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.


The information disclosed by the speakers, planning committee, and reviewers was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and Aspen Allergy Conference. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 15.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on June 30, 2023. Requests to claim credit on or after July 1, 2023 will be subject to an administrative fee.

Medium and Method of Physician Participation for a Live Activity
Follow these steps to complete the activity:

  1. Register for the activity.
  2. Review the CME and Disclosure information.
  3. View pre-meeting information and/or complete the pre-test (if applicable)
  4. Attend the meeting. Be sure to sign in so your attendance can be recorded.
  5. Return to the online meeting site after the meeting and complete the post-test (if applicable - you must achieve a score of 70% or higher on post-tests to claim credit)
  6. Complete the activity evaluation.
  7. Claim your credits. Enter only the number of credits earned based on your participation in the activity.
  8. Print or save your certificate.

Activity-related questions should be directed to Jill Hibbeln at Aspen Allergy Conference (jillhibbeln@gmail.com).

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 15.50 Attendance
    Attendance credit.
  • 15.50 CME
    CME credit.


Please login or register to take this course.
By registering for this educational activity you are confirming that you have read the Privacy and Data Protection Notice and agree to the terms as outlined below:
Privacy and Data Protection Notice

The American Academy of Allergy, Asthma & Immunology (AAAAI) takes your privacy seriously. AAAAI will only use your personal information to administer your registration, attendance, and credit claiming/attendance record for this activity, to provide services that you have requested from AAAAI and otherwise as you may expressly consent. A complete copy of AAAAI’s Legal and Privacy Notices, the terms of which are incorporated herein, can be found here.

By providing consent, you are allowing AAAAI to process your personal data. AAAAI will collect and store information you provide in the Registration/Housing Forms for the purposes of enabling us to register your attendance at the activity; to assist with administrative, planning and marketing purposes; and to allow the compilation and analysis of statistics relevant to AAAAI.

The information you provide in the Registration/Housing Forms, and information provided at any other time during this activity, including without limitation any feedback obtained during the activity, will be used by AAAAI to offer, provide and continue to improve its educational activities and other services. The AAAAI will also use your email address to communicate important information regarding this activity and for marketing purposes for future activities. AAAAI will not otherwise, without your consent, use or disclose your personal information for any purpose unless it would reasonably be expected that such a purpose is related to the offer, provision and improvement of the activity or where such purpose is permitted or required by law.

For courses/events with industry support and/or exhibitors, The AAAAI may disclose some information that is collected in the Registration Form such as your name, credentials, title/position, organization, and mailing address to exhibitors and industry supporters for marketing purposes such as to receive mailed literature. In addition to, but separate from, your consent regarding being contacted by exhibitors and industry supporters with mailed literature, when you visit sponsored areas within the virtual platform for an online event (such as, but not limited to, an exhibitor’s virtual exhibit booth), that organization will receive your personal contact information (name, credentials, title/position, organization, mailing address, phone number, email address and NPI number, if applicable). If you do not want to share your personal contact information with any/all of those organizations, please do not visit those areas within our virtual platform. By accessing any/all of those areas in our virtual platform, you are consenting to share your personal contact information with all organizations whose sponsored areas you visit in our virtual platform. If you attend this activity in person, and provide your contact information to an exhibitor or industry supporter (including allowing them to scan your name badge), you are consenting to share your personal contact information with that organization. You have the right to decline an exhibitor and/or industry supporter’s request for your personal contact information. AAAAI does not control the use or distribution of personal contact information transferred when you visit a sponsored area in the virtual platform or, if in person, when you share your personal contact information, and as such, AAAAI shall not be held responsible for any misuse of your personal data obtained by exhibitors or industry supporters in this manner. You have the right to ask the exhibitor or industry supporter questions about how they will use your personal data, how long it will be retained and if they will share information with third parties.

After you have submitted your personal contact information in the registration form, you may change your preferences for receiving emails by following the instructions below:
·    To change your preferences for receiving emails from AAAAI regarding future annual meetings and/or other in-person and online education programs, please visit http://aaaai.execinc.com/edibo/Profile
·    For events where industry support or exhibitions are involved please email cme@aaaai.org to change your consent to be contacted by the industry supporters and exhibitors of that activity.

NOTE: AAAAI  may be photographing this activity. These photographs, along with your name, may be used in AAAAI publications or on the AAAAI website. If you do not want your photo used, please inform the staff photographer at the time the photograph is taken. AAAAI may also be audio recording education sessions during this activity. If you verbally submit any questions for Question & Answer sessions (Q&A), you are agreeing to be recorded and to have that recording available in enduring materials. If you prefer not to be audio recorded, please submit any questions you have in writing.

I understand that it is my right to withhold consent to the above Privacy and Data Protection Notice, or to withdraw my previous consent at any time. I further understand that without my consent, it is not possible to process my registration/housing request for this activity. Please contact the AAAAI Education Team at (414) 272-6071 if you have any further questions about how this will affect your registration/housing request for this activity.

Required Hardware/software

One of the two latest versions of Google Chrome, Microsoft Edge, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.